University of California San Francisco

Publications

  1. Combination Immunotherapy With LIGHT and Interleukin-2 Increases CD8 Central Memory T-Cells In Vivo.
    Fernandez MF, Qiao G, Tulla K, Prabhakar BS, Maker AV
    PubMed
  2. LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.
    Qiao G, Qin J, Kunda N, Calata JF, Mahmud DL, Gann P, Fu YX, Rosenberg SA, Prabhakar BS, Maker AV
    Cancer Res. 2017 04 15; 77(8):1880-1891.; 
    PubMed
  3. Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.
    Wiley MB, Bauer J, Mehrotra K, Zessner-Spitzenberg J, Kolics Z, Cheng W, Castellanos K, Nash MG, Gui X, Kone L, Maker AV, Qiao G, Reddi D, Church DN, Kerr RS, Kerr DJ, Grippo PJ, Jung B
    Cancers (Basel). 2023 May 31; 15(11).; 
    PubMed
  4. MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
    Saini S, Sripada L, Tulla K, Qiao G, Kunda N, Maker AV, Prabhakar BS
    Endocr Relat Cancer. 2019 06 01; 26(6):551-563.; 
    PubMed
  5. Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases.
    Keenan BP, Qiao G, Kunda N, Kone L, Guldberg SM, Todeschini L, Kumar P, Pollini T, Hernandez S, Qin J, Fong L, Spitzer MH, Prabhakar BS, Maker AV
    Sci Adv. 2025 Oct 10; 11(41):eadv9161.; 
    PubMed
  6. Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death.
    Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, Maker AV
    Cell Death Dis. 2017 02 02; 8(2):e2584.; 
    PubMed
  7. LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer.
    Qiao G, Kone LB, Phillips EH, Lee SS, Brown GE, Khetani SR, Thakur A, Lum LG, Prabhakar BS, Maker AV
    Oncogene. 2022 04; 41(14):2054-2068.; 
    PubMed
  8. Vaccination With Mitoxantrone-Treated Primary Colon Cancer Cells Enhances Tumor-Infiltrating Lymphocytes and Clinical Responses in Colorectal Liver Metastases.
    Qin J, Kunda NM, Qiao G, Tulla K, Prabhakar BS, Maker AV
    J Surg Res. 2019 01; 233:57-64.; 
    PubMed
  9. Novel Computational Analysis Identifies Cytotoxic Lymphocyte-to-Monocyte Balance in Tumors as a Predictor of Recurrence-Free Survival in Colorectal Carcinoma.
    Fernandez M, Todeschini L, Keenan BP, Rosenberg D, Hernandez S, Zampese M, Qiao G, Pollini T, Maker AV
    Ann Surg Oncol. 2025 Sep; 32(9):6980-6990.; 
    PubMed
  10. Targeting the metabolic pathway of human colon cancer overcomes resistance to TRAIL-induced apoptosis.
    Carr RM, Qiao G, Qin J, Jayaraman S, Prabhakar BS, Maker AV
    Cell Death Discov. 2016; 2:16067.; 
    PubMed